Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women.

Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A.

J Sex Marital Ther. 2001 May-Jun;27(3):303-16.

PMID:
11354935
2.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
3.

The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

Krapf JM, Simon JA.

Maturitas. 2009 Jul 20;63(3):213-9. doi: 10.1016/j.maturitas.2009.04.008. Epub 2009 May 31. Review.

PMID:
19487090
4.

Low sexual desire--is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder.

Simon JA.

Postgrad Med. 2010 Nov;122(6):128-36. doi: 10.3810/pgm.2010.11.2230. Review.

PMID:
21084789
5.

Role of testosterone in the treatment of hypoactive sexual desire disorder.

Schwenkhagen A, Studd J.

Maturitas. 2009 Jun 20;63(2):152-9. doi: 10.1016/j.maturitas.2009.02.011. Epub 2009 Apr 8. Review.

PMID:
19359109
6.

Opportunities for intervention in HSDD.

Simon JA.

J Fam Pract. 2009 Jul;58(7 Suppl Hypoactive):S26-30. Review.

PMID:
19825316
7.
8.

The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder.

Sills T, Wunderlich G, Pyke R, Segraves RT, Leiblum S, Clayton A, Cotton D, Evans K.

J Sex Med. 2005 Nov;2(6):801-18.

PMID:
16422805
9.

From whence comes HSDD?

Parish SJ.

J Fam Pract. 2009 Jul;58(7 Suppl Hypoactive):S16-21. Review.

PMID:
19825314
10.

Testosterone supplementation for hypoactive sexual desire disorder in women.

Woodis CB, McLendon AN, Muzyk AJ.

Pharmacotherapy. 2012 Jan;32(1):38-53. doi: 10.1002/PHAR.1004. Review.

PMID:
22392827
11.

[Hypoactive sexual desire disorder, HSDD].

Mimoun S.

Gynecol Obstet Fertil. 2011 Jan;39(1):28-31. doi: 10.1016/j.gyobfe.2010.10.016. Epub 2010 Dec 24. Review. French.

PMID:
21186133
12.

Hypoactive sexual desire disorder: an overview.

Beck JG.

J Consult Clin Psychol. 1995 Dec;63(6):919-27. Review.

PMID:
8543714
13.

Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.

Dhanuka I, Simon JA.

Expert Opin Pharmacother. 2015;16(16):2523-9. doi: 10.1517/14656566.2015.1090426. Epub 2015 Sep 22. Review.

PMID:
26395164
14.

Hypoactive sexual desire disorder.

Davison SL.

Curr Opin Obstet Gynecol. 2012 Aug;24(4):215-20. doi: 10.1097/GCO.0b013e328355847e. Review.

PMID:
22729093
15.

Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options.

Croft HA.

J Sex Med. 2017 Dec;14(12):1575-1584. doi: 10.1016/j.jsxm.2017.10.068. Review.

PMID:
29198512
16.

Hypoactive sexual desire disorder in premenopausal women: case studies.

Miner M, Sadovsky R, Buster JE.

Postgrad Med. 2012 Jan;124(1):94-103. doi: 10.3810/pgm.2012.01.2522. Review.

PMID:
22314119
17.

The causes and prevalence of hypoactive sexual desire disorder: part I.

Feldhaus-Dahir M.

Urol Nurs. 2009 Jul-Aug;29(4):259-60, 263. Review.

PMID:
19718942
18.
19.

Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment.

Warnock JJ.

CNS Drugs. 2002;16(11):745-53. Review.

PMID:
12383030
20.

Naltrexone sustained-release (SR) + bupropion SR combination therapy for the treatment of obesity: 'a new kid on the block'?

Katsiki N, Hatzitolios AI, Mikhailidis DP.

Ann Med. 2011 Jun;43(4):249-58. doi: 10.3109/07853890.2010.541490. Epub 2011 Jan 24. Review.

PMID:
21254901

Supplemental Content

Support Center